India recommends homemade COVID-19 vaccine for kids aged 2 and above

imageWorld6 minutes ago (Oct 12, 2021 07:00AM ET)

(C) Reuters. FILE PHOTO: A woman stands with her children as she waits to receive a dose of COVAXIN coronavirus disease (COVID-19) vaccine manufactured by Bharat Biotech, during a vaccination drive organised by SEEDS, an NGO which normally specialise in providing reli

BENGALURU (Reuters) -India on Tuesday recommended emergency use of Bharat Biotech’s COVID-19 shot in children below 12 years of age, making the vaccine maker the first in the country to get such an approval after a review of its trial data for the 2-18 age-group.

The decision comes as India shifts its focus to vaccinating children against the coronavirus, having already rolled out more than 950 million doses to adults among its population of nearly 1.4 billion.

Bharat Biotech’s Covaxin, which uses an inactivated coronavirus with an immunity booster, is among the three shots that are being used in India as part of the vaccination drive for adults.

More than 110 million doses of Covaxin have been administered and the company is in the process of securing an emergency use listing from the World Health Organization, a decision that is expected later this month.

To be sure, without the WHO nod, the two-dose shot is unlikely to be accepted as a valid vaccine around the world.

“Children with comorbidities should be vaccinated as soon as possible now that a vaccine with immunogenicity in children and a large safety database in adults is available,” said Dr Gagandeep Kang, professor at Christian Medical College, Vellore.

“For healthy children, given low risk and low virus circulation at the moment, it is safe to wait until more adults are covered.”

Bharat Biotech began a trial of Covaxin in children in June following a devastating second wave of COVID-19 led by the Delta variant that brought country’s healthcare system to its knees.

The data for the 2 to 18 age-group “has been thoroughly reviewed by the Central Drugs Standard Control Organisation and Subject Expert Committee and (they) have provided their positive recommendations,” the company told Reuters.

Bharat Biotech has not publicly shared the efficacy and safety data for children.

So far, only drugmaker Zydus Cadila’s DNA-based vaccine had been authorized for emergency use in children aged at least 12 years.

India recommends homemade COVID-19 vaccine for kids aged 2 and above

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


Subscribe here

Read More